Page URL:

Injectable gene therapy 'could prevent heart attacks'

16 June 2014
Appeared in BioNews 758

A gene linked to cholesterol levels has been successfully edited in mice after they were given a single injection, thereby reducing their risk of heart disease, according to a study.

Researchers altered the DNA of a virus using a type of gene editing technology called CRISPR/Cas9. They then injected this virus into mice, where it altered the function of a liver gene called PCSK9. This then resulted in a 35-40 percent reduction of cholesterol in the blood, a similar reduction seen in people using cholesterol-lowering drugs.

Dr Kiran Musunuru, the senior author from Harvard Stem Cell Institute, said: 'The first question was whether we could get CRISPR/Cas9 into the liver, and once we got it into the liver, would it function properly, and it did'.

Describing the 'dramatic effect', he said: 'Within three to four days of delivering the system into the liver the majority of the PCSK9 gene copies in all of the liver cells were disrupted, knocked out, and what we hoped to see was much less of the protein product in the bloodstream, which is what we saw'.

If this technology is found to be effective and safe to use in humans, the researchers say that a similar reduction in cholesterol could reduce the risk of heart attacks by up to 90 percent.

'It's not too much of a leap to think that if it works as well in mice, it will work as well in humans', said Dr Musunuru. By developing an injection containing the genome editing technology, he hopes to 'make normal people like people born with the "good" mutations'.

Previous research had shown that around three percent of the population have a mutation in PCSK9 that leads to lower levels of low-density lipoprotein (LDL or 'bad cholesterol') and that they have a 47-88 percent reduced risk of heart attacks compared with the general population.

Dr Musunuru said: 'Our reasoning was that nature has already done the experiment; you have people who have won the genetic lottery'. He continued, 'They are protected from heart attack, and there are no known adverse consequences. So that led us to reason that if we could find a way to replicate this, we could significantly protect people from heart attack'.

Although this research shows that a single injection to reduce cholesterol in humans is plausible, the genome-editing technique used is very new (as reported in BioNews 730) and more research is needed to assess its safety in humans.

A single injection to stop heart attacks? Jab that slashes risk by 90% by 'knocking out' gene linked with cholesterol could be available within ten years
Daily Mail |  11 June 2014
A vaccination to prevent heart attacks?
Harvard Stem Cell Institute (press release) |  9 June 2014
Cholesterol Controlled for Good by Gene Therapy in Mice
Bloomberg |  11 June 2014
Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
Circulation Research |  10 June 2014
Single injection to cut risk of heart attack
Daily Telegraph |  10 June 2014
16 July 2018 - by Dr Alexander Ware 
Researchers have successfully used genome editing to reduce blood cholesterol in living monkeys...
15 December 2014 - by Dr Molly Godfrey 
Scientists have identified a set of rare gene mutations that may increase the risk of early heart attacks...
18 November 2014 - by Dr Lanay Griessner 
An inactive copy of a gene associated with cholesterol levels can reduce the risk of a heart attack, according to a study...
18 August 2014 - by Isobel Steer 
A gene therapy trial has been launched to help people with advanced heart failure who must constantly carry a bulky battery to power an artificial heart pump....
21 July 2014 - by Dr Rachael Panizzo 
Adult heart cells can be genetically reprogrammed into pacemaker cells by injecting a gene into the heart, an experiment in pigs suggests...
12 May 2014 - by Dr Greg Ball 
Two major reviews of clinical trials using stem cells to treat advanced heart disease have found a positive effect of the stem cell treatment, but caution against overstating this effect until more trials are carried out...
6 May 2014 - by Dr Rachael Panizzo 
Heart cells derived from human embryonic stem cells are capable of regenerating damaged heart muscle in primates, a US study has found...
9 September 2013 - by Siobhan Chan 
The first patients from two separate ongoing studies have been treated using gene and stem cell therapies to repair damage caused by heart attacks...
27 August 2013 - by Lanay Tierney 
Researchers have concocted a 'gene cocktail' that may help to turn scar tissue into functioning cardiac cells after a heart attack...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.